Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2921
Selected: 0
NCT IDTitle
NCT03219671Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)
NCT01396252Japanese Phase 1 Multiple Ascending Dose (MAD) Study
NCT00803647A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
NCT06951698A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
NCT01620944Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC
NCT00362258I PREVENT - Irbesartan In Hypertensive Diabetic Patients
NCT00002207A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients
NCT02775292Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
NCT05375084SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation
NCT00024284Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
NCT03918252Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
NCT03642067Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
NCT03035734Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants
NCT05827016A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
NCT04161911A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy
NCT06163040A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
NCT02778906Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
NCT06422247Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy
NCT02345343Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico
NCT03953235A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens
NCT00718887Suboptimal Responders to Adefovir Switching to Entecavir
NCT03891524A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
NCT03724968Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression
NCT04289259Tumor Mutational Burden in Lung Cancer Patients
NCT03950960A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of BMS-986256 in Healthy Participants
NCT00279760Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
NCT02516527A Phase 1 Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors
NCT04021108Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
NCT02790125A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects
NCT02346942Factors Associated With Biologic DMARD Switching
NCT00982488Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT05382715A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis
NCT03792750A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors
NCT00005918Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
NCT00918385Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer
NCT00000625A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
NCT02439190CV004-007 Thrombosis Chamber Study
NCT00768989Phase IIB Pilot of Atazanavir + Raltegravir
NCT06122779Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT03316274Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
NCT05284890A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants
NCT01450605Korean Post-marketing Surveillance for Reyataz®
NCT00833703Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation
NCT03487666OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease
NCT03611751An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
NCT03262740The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
NCT05200988Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
NCT06788691Luspatercept for Clonal Cytopenias of Uncertain Significance
NCT05065762Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment
NCT04090710SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer